Source: CosmeticsDesign

Conagen: Biotech company develops 'first-of-its-kind' retinol derivative for cosmetic & PBC product formulation

The retinoid-derivative ingredients, which can be combined with a secondary ingredient for further efficacy or improved effectiveness, are a novel option for manufacturers looking to avoid the potential unwanted secondary effects of traditional retinoids.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Oliver Yu's photo - Co-Founder & CEO of Conagen

Co-Founder & CEO

Oliver Yu

CEO Approval Rating

84/100

Read more